| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |